TCT 2019: IDEAL LM Inconclusive, While Onyx ONE Boosts Polymer-Based DES

 
• By Phil Greenfield

Data from two late-breaking drug-eluting stent trials, presented on 26 September at Transcatheter Cardiovascular Therapeutics meeting in San Francisco, prompted mixed reactions from interventional cardiologists.

Skyscrapers in San Francisco at night - Image
The Transcatheter Cardiovascular Therapeutics conference is held in San Francisco from 24 September to 29 September • Source: shutterstock.com

More from Clinical Trials

More from R&D